Marlan D. Walker, Chief Executive Officer at TherapeuticsMD, Inc. (TXMD), bought 2,303 shares at $0.86 ($2K) on 2025-04-10, disclosed to the SEC on 2025-04-10.
Open-market purchase of $2k TXMD by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.87 | 1,136 | $988 | 49.6% |
| 2 | $0.86 | 1,167 | $1K | 50.4% |
| Total | $0.86 avg | 2,303 | $2K | 100% |
| Filing → |
| TXMD | SELL | 2023-05-04 | $3K | — | Filing → |
| TXMD | SELL | 2023-04-14 | $4K | — | Filing → |
| TXMD | SELL | 2022-12-09 | $5K | — | Filing → |